As a step toward combating global warming, the Obama Administration has released its strategy to reduce methane-emissions in the US. The Administration’s goal is for emissions to be cut by 2020 to 17% below 2005 levels. The methane-reduction strategy for oil and gas production includes updating standards for public lands and supporting technologies for detecting […]
The US’s Protecting Access to Medicare Act of 2014 became law this month and shifts the determination of Medicare payments for clinical lab tests to a market-based system. Starting in January 2017, the Centers for Medicare & Medicaid Services (CMS) will set the Medicare payment rates for clinical lab tests by using the weighted median […]
At a time when large exhibitions seem to be declining in attendance and exhibitor participation, Analytica has clearly established itself as a “must-attend event” based on a proven formula for success. The trade fair took place May 10–13 in Munich, Germany. Held at an outstanding modern venue in the heart of Europe, well planned and […]
Notwithstanding currency, there were only subtle changes in the 2013 calendar-year rankings on IBO’s list of the top 30 analytical and life science instrument and aftermarket companies as a result of modest growth and fewer acquisitions. However, Illumina was the highlight, rising one spot to the number nine position, with more than 20% sales growth […]
Final Pittcon 2014 attendance figures have been released, updating the figures in the March 15 issue of IBO. Total attendance declined 10.7% to 16,255. The number of conferees (excluding exhibitors, students and media) declined 12.6% to make up 59% of attendees. The number of exhibitor personnel fell 9.3% to 6,220. Thirty-six percent of conferees were […]
Chemical companies in the US and Europe plan to increase their research and capital spending in 2014, according to a survey conducted by Chemical and Engineering News (C&EN). This year will mark the fifth year of capital spending increases for 20 major chemical firms. Their total projected expenditures for facilities and equipment in 2014 is […]
A report submitted to the US Congress by the Office of Science and Technology Policy details spending on R&D infrastructure. In 2013, $1,710 million was spent on construction of nondefense facilities and capital equipment. A 37.4% increase is estimated for 2014 spending for a total of $2,350 million. However, infrastructure spending for the NIH is […]
Funding for R&D is undergoing a shift in the US, with an increasing trend toward private backing. While federal funds still provide most of the support for the sciences, budget cuts have placed financial strain on some research institutes and programs. According to one study of the 50 universities with the highest budgets for science […]
Pittcon returned to Chicago, Illinois, this year, from March 2 to 6, marking its first trip back to the city since 2009. The conference received a chilly reception, as temperatures dipped below 10° F (-12° C). The weather may have affected day visitors, as the total number of attendees fell 17.0% to 15,104 (according to […]
US President Obama has submitted his 2015 budget request, totaling $3.9 trillion, to Congress. Agencies funding scientific research did not fare well, with increases insufficient to offset inflation in most cases. The requested $30.4 billion budget for the NIH’s is only a 0.7% increase. However, the NIH’s spending for the BRAIN initiative (see IBO 4/15/13) […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
